Remedial Health is a company focused on enhancing access to medicines for healthcare retail businesses, including large pharmacies and small chemist shops. By utilizing advanced technology, it develops a pharmacy operations and procurement management platform that facilitates direct ordering from manufacturers and registered distributors. This platform supports both large and small retailers in streamlining their dispensing and workflow management processes, ensuring just-in-time stock availability. Additionally, Remedial Health provides financing options and a diverse selection of inventory, thereby improving the efficiency and effectiveness of medicine procurement for its clients.
Nanopath Inc. is a molecular diagnostics company enabling high-quality molecular testing in minutes.
Moving Analytics. is a tele-health company dedicated to helping people thrive after heart disease. Our flagship product is Movn a virtual cardiac rehabilitation program that leverages evidence based guidelines, behavioral science, remote monitoring and personalized coaching to help patients recover to full health after a cardiac event. Movn is currently used by the Veterans Affairs Medical Center, Highmark Health Plan, Kaiser Permanente Northwest and many more health systems across the US.
Swing Therapeutics focuses on developing innovative digital therapeutics aimed at helping individuals with chronic conditions. The company collaborates with leading researchers to create evidence-based treatments that enhance patient empowerment and control over their health. By offering novel prescription digital therapeutics, Swing supports patients in managing their illnesses more effectively, ultimately fostering improved health outcomes and promoting a more vibrant quality of life.
Sesame, Inc., operating as SesameCare, is a company that offers a platform for booking doctor appointments and accessing medical care. Founded in 2018 and based in New York, SesameCare aims to simplify the healthcare experience by connecting patients directly with doctors, providing upfront pricing and clear descriptions of medical services. This approach is particularly beneficial for uninsured individuals or those opting to pay out-of-pocket, as it addresses common issues such as hidden costs and unexpected charges that often complicate healthcare access. By focusing on transparency and affordability, SesameCare endeavors to make quality healthcare more accessible for all patients.
Aware Healthcare is a VC-backed digital healthcare startup on a mission to build the “thermometer for the mind”: a digital medical device that delivers real-time measures of clinical risk at the moments patients and providers need it most. We envision a world where we all have the self-awareness to identify when we’re heading down a dark path, vocabulary to describe how we’re mentally feeling, and tools to get help in minutes not weeks.
Quadrant Health, founded in 2021 by Krishna Gorrepati and Anin Sayana, specializes in providing real-time analysis of electronic health records (EHR) and patient messaging data. The company has developed a cloud-based disease prediction platform that employs machine learning algorithms to identify potential health risks, such as infections and injuries, before symptoms manifest. This innovative approach enables healthcare providers to proactively manage patient care, enhancing their ability to prevent harm and improve overall patient outcomes. By focusing on early detection, Quadrant Health aims to transform preventative medicine and support healthcare professionals in delivering more effective care.
Pharmacy Marts is an online platform that enables pharmacists to get their daily prescriptions and medications from a variety of suppliers. Pharmacy Marts was founded in 2021 and is located in Cairo, Egypt.
Miga is a virtual cardiometabolic clinic that focuses on improving heart health through an innovative platform that combines gamified mobile applications with comprehensive clinical services. Founded by Jarrad Aguirre, MD, and Dre Limberopoulos, Miga's offerings include at-home monitoring for blood pressure, telemedicine consultations, mail-order pharmacy services, and lifestyle coaching. The clinic addresses various cardiometabolic conditions such as obesity, hypertension, diabetes, and hyperlipidemia, empowering patients to manage their health effectively and reduce the risk of serious heart issues, including premature heart attacks and strokes.
Cylera, Inc., founded in 2017 and based in New York, provides cybersecurity solutions specifically designed for healthcare organizations. The company focuses on protecting patients and healthcare providers from cyber threats, including malware. Its centralized cybersecurity software offers a comprehensive platform that identifies and assesses risks across various devices, such as medical equipment, operational technology, and enterprise IoT. By employing a patient-centric approach, Cylera enables healthcare institutions to detect threats and respond to them in real-time, ensuring the security and integrity of critical healthcare operations.
Legion Health operates a platform that connects telehealth companies with a network of highly-vetted clinicians, facilitating access to mental health services. By leveraging artificial intelligence, Legion Health streamlines the psychiatric care process, allowing healthcare organizations to efficiently scale their virtual behavioral health offerings. The platform enables patients to receive timely care from qualified providers while minimizing the administrative burdens often faced by clinicians. This approach not only enhances the patient experience but also allows healthcare organizations to meet growing demands for mental health services in a more effective manner.
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
Developer of a mental health platform intended to improve access to convenient and accessible mental health care. The company's platform delivers personalized treatment services that leverage evidence-based therapeutics and technologies, transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine, enabling patients to notice meaningful outcomes and achieve mental well-being through effective and affordable treatments.
Mantra Health is a developer of a mental healthcare platform specifically designed to cater to students. The platform provides access to psychiatric care, free online assessments, and scheduled initial video consultations, allowing students to receive personalized care plans. By facilitating treatment in a comfortable and accessible manner, Mantra Health aims to enhance the mental well-being of students, making it easier for them to seek help and manage their mental health from the convenience of their homes.
Droplette Inc., established in 2017 and based in Boston, Massachusetts, specializes in the development of a needle-free skincare device that utilizes a patent-pending transdermal delivery system. This innovative technology allows for the delivery of ingredients under the skin's surface, reaching depths suitable for larger molecules than traditional methods. The device is designed to be painless, portable, and environmentally friendly, generating no disposables. It has applications in delivering antibiotics for serious ulcers and skin infections, thereby reducing the risk of complications and antibiotic resistance. Future uses may include targeted delivery of chemotherapeutics for skin cancer and other therapeutic agents aimed at anti-aging. Through its scientific advancements, Droplette aims to enhance skin health while providing a safer alternative to conventional skincare treatments.
Luma Health Inc. is a San Francisco-based company that develops a patient engagement platform aimed at facilitating communication between healthcare providers and patients. Founded in 2015, the platform is designed to help healthcare systems and clinics efficiently manage patient appointments, including smart scheduling and referral management. It also offers features such as appointment reminders, mobile patient intake, care pathways, and EHR integrations, alongside analytics and insights. By connecting patients to care quickly and ensuring adherence to treatment plans, Luma Health enhances the overall patient experience and helps healthcare providers maintain a full schedule while improving treatment procedures.
Gordy Health is a virtual care provider exclusively focused on blood pressure management to lower patients’ risk for heart attack, stroke, and kidney failure. The company aims to prevent complications from high blood pressure to have healthier lives and live longer. Gordy Health was founded in 2021 and is based in Pasadena, California.
Developer of an online teleconsultation platform designed to guide women during and after menopause. The company's platform has online access to specialized doctors, science-backed pieces of information and treatments with conversations and information about effective care for changing hormones, enabling women to live longer and healthier lives.
Olaris, Inc. is a biotechnology company based in Waltham, Massachusetts, focused on developing a precision medicine diagnostic platform aimed at improving disease diagnosis and treatment. Founded in 2013, Olaris specializes in metabolite profiling and personalized biomarkers of response, utilizing advanced machine learning algorithms. This innovative approach allows healthcare providers to identify the most effective treatments for individual patients, thereby optimizing clinical outcomes and minimizing adverse effects associated with therapies. Through its metabolomics platform, Olaris seeks to transform the way diseases, particularly breast cancer, are diagnosed and managed.
GritWell Ltd is a digital health platform that connects patients with chronic health conditions to a network of nutritionists, health coaches, and various types of doctors, including functional, holistic, and naturopathic practitioners. The platform facilitates secure video consultations and direct messaging, allowing users to receive credible health advice and personalized long-term treatment plans. Additionally, GritWell offers referrals for further diagnostic testing, enhancing the continuity of care for patients. For healthcare practitioners, the platform provides a comprehensive dashboard to efficiently manage their practice, featuring tools for online scheduling, patient records, conversation notes, and treatment plans. Founded in 2018, GritWell is headquartered in San Francisco, California.
Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise. The company works with medical researchers and patient advocacy organizations to provide prescriptions to any patient using their mobile devices. Blue Note Therapeutics was founded in 2018 and is based in San Francisco, California.
Kenshō is a health company based in Los Angeles that operates an online platform designed to connect users with verified wellness providers. Founded by entrepreneurs Krista Berlincourt and Danny Steiner, the company emphasizes a holistic approach to health, integrating mind, body, and spirit. Kenshō's platform allows users to easily find and book a variety of wellness services, including acupuncture, massage, yoga, naturopathy, and meditation, facilitating access to curated professionals without the need for in-person visits. By combining scientific research with personalization technology, Kenshō aims to simplify the journey toward holistic health, providing users with trustworthy answers and resources for maintaining a balanced and healthy lifestyle.
AdaptX operates a healthcare data analytics platform that focuses on delivering automated analytics to frontline clinical staff. Founded in 2016 and based in Seattle, the company emerged from Seattle Children's Hospital and serves hospitals and surgery centers. Through its innovative solutions, AdaptX empowers medical leaders and clinicians to access and analyze data effectively, enabling them to enhance clinical and workflow outcomes. This approach not only improves patient care but also helps reduce costs, thereby transforming clinical operations within the healthcare sector.
Asto CT LLC specializes in developing X-ray computed tomography (CT) systems specifically for equine imaging, aimed at enhancing the care and safety of thoroughbreds, show, recreational, and older horses. Founded in 2015 and based in Madison, Wisconsin, the company offers advanced imaging solutions that improve fracture risk detection, diagnose lameness, and address dental and sinus issues without the need for general anesthesia. Their flagship product, Equina, provides rapid 3D imaging of horses' lower limbs, head, and neck while ensuring a safe and comfortable environment for the animals. By integrating cutting-edge robotics with advanced multi-slice CT technology, Asto CT enhances veterinary diagnostics and treatment, particularly for conditions affecting the distal limb and diseases of the head and neck.
SHINE Medical Technologies, LLC is a manufacturer and supplier of medical tracers and cancer treatment elements, specializing in isotopes used for diagnostic and therapeutic purposes. The company produces molybdenum-99, which is essential for imaging and diagnosing conditions such as cancer and heart disease. Additionally, SHINE offers Iodine-131 for the treatment of thyroid cancer and related conditions, as well as Iodine-125, which is utilized in brachytherapy for various cancers. The company also provides Xenon-133, an inhalable gas that assists in evaluating lung function and blood flow in the brain. Founded in 2010 and headquartered in Janesville, Wisconsin, SHINE serves both domestic and international markets with its innovative medical solutions.
Veralox Therapeutics specializes in the development of small molecule therapeutics aimed at addressing the underlying causes of thrombosis and type one diabetes. By leveraging a deep understanding of the molecular mechanisms associated with these conditions, the company seeks to create innovative treatment options that can lead to improved health outcomes for patients. Their focus includes therapies specifically targeting heparin-induced thrombocytopenia and thrombosis, with the goal of providing patients with effective solutions for complete recovery from diabetes and associated complications.
miRecule, Inc. is a biotechnology company specializing in the development of microRNA-based therapeutics, with a focus on addressing challenges in cancer treatment and other diseases such as muscular dystrophy. Founded in 2016 and headquartered in Gaithersburg, Maryland, the company has created a drug discovery platform called DREAmiR. This platform leverages genomic and outcome data from thousands of patients to identify genetic changes linked to diseases. It combines genomic sequencing, expression, and prognostic data from cancer patients with high-throughput screening data to pinpoint microRNA candidates for replacement therapy. miRecule's approach aims to formulate these candidates into tumor-targeted nanoparticles, enabling oncologists to effectively target and eliminate drug-resistant cancer cells.
Strategikon Pharma, Inc. is a technology firm that specializes in the design and development of software solutions aimed at optimizing the outsourcing processes in the pharmaceutical industry. Its flagship product, Clinical Maestro, is a cloud-based platform that facilitates end-to-end management of clinical business operations, including planning, outsourcing, and financial management of clinical trials. This software creates a collaborative virtual environment that enhances communication and data integration between pharmaceutical companies and their service providers, moving away from traditional, labor-intensive methods such as Excel. By providing tools for clinical financial management, vendor performance metrics, and contract lifecycle management, Clinical Maestro enables biopharmaceutical firms to streamline their operations and reduce costs significantly. Founded in 2016 and headquartered in San Rafael, California, Strategikon also offers consulting services to support the establishment of clinical business operations for new entrants in the field.
pulseData, Inc. is a New York-based company founded in 2015 that specializes in developing machine learning software tailored for healthcare providers. The company's platform leverages adaptive and predictive data science tools to identify patients at risk of adverse medical outcomes, enabling healthcare organizations to deliver targeted care to those who need it most. By analyzing vast amounts of data, including individual patient information and population patterns, pulseData aids care management teams in providing timely and effective interventions. This approach not only enhances patient care but also aims to reduce preventable illnesses and optimize medical cost savings for healthcare enterprises.
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.
Kenshō is a health company based in Los Angeles that operates an online platform designed to connect users with verified wellness providers. Founded by entrepreneurs Krista Berlincourt and Danny Steiner, the company emphasizes a holistic approach to health, integrating mind, body, and spirit. Kenshō's platform allows users to easily find and book a variety of wellness services, including acupuncture, massage, yoga, naturopathy, and meditation, facilitating access to curated professionals without the need for in-person visits. By combining scientific research with personalization technology, Kenshō aims to simplify the journey toward holistic health, providing users with trustworthy answers and resources for maintaining a balanced and healthy lifestyle.
Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.
Ellipsis Health, Inc. is a technology company based in San Francisco, California, that specializes in developing tools to enhance behavioral health through innovative analytics solutions. Founded in 2013, the company utilizes artificial intelligence to analyze patient speech and clinical data, creating a real-time, behavioral health vital sign for individuals. This platform provides a clinical-grade assessment of anxiety and depression severity, as well as sub-clinical evaluations of stress. By enabling healthcare systems to continuously screen for mental health conditions, Ellipsis Health aims to support patients in receiving timely and appropriate care, focusing primarily on depression and anxiety.
Expectful is a digital subscription platform that makes it easy for expectant and new moms to meditate.
Strategikon Pharma, Inc. is a technology firm that specializes in the design and development of software solutions aimed at optimizing the outsourcing processes in the pharmaceutical industry. Its flagship product, Clinical Maestro, is a cloud-based platform that facilitates end-to-end management of clinical business operations, including planning, outsourcing, and financial management of clinical trials. This software creates a collaborative virtual environment that enhances communication and data integration between pharmaceutical companies and their service providers, moving away from traditional, labor-intensive methods such as Excel. By providing tools for clinical financial management, vendor performance metrics, and contract lifecycle management, Clinical Maestro enables biopharmaceutical firms to streamline their operations and reduce costs significantly. Founded in 2016 and headquartered in San Rafael, California, Strategikon also offers consulting services to support the establishment of clinical business operations for new entrants in the field.
Mureni, S.A.P.I. DE C.V. is a healthcare startup based in Mexico City that specializes in designing and developing invisible dental aligners. The company provides a range of services including x-rays, 3D scans, and evaluation photographs to facilitate effective dental treatment. By utilizing advanced three-dimensional scanning and printing technologies, Mureni enables customers to receive orthodontic care that is metal-free and minimizes discomfort, allowing for treatment without the need for frequent visits to an orthodontist. Operating primarily in Mexico and Brazil, Mureni aims to assist dentists in Latin America in enhancing their revenue and streamlining their operations through innovative technology solutions.
TwentyEight Health, Inc. operates an online platform focused on women's reproductive and sexual health. Founded in 2018 and based in Brooklyn, New York, the company aims to enhance access to healthcare services, particularly in the area of birth control. It offers online doctor evaluations for birth control prescriptions, expedites home deliveries, and provides secure messaging with healthcare professionals. In addition to these services, TwentyEight Health features sex education content that is vetted by doctors, empowering women to understand their options regarding reproductive health. The platform is designed to provide a convenient and affordable way for women to access necessary healthcare services.
Small Door provides veterinary services that are elevated, customer-centric, and hospitality-infused. The company provides superior care, unrivaled transparency, and tech-enabled convenience to help pets and pet parents live better lives together. Founded in 2017, Small Door is headquartered in New York.
Generate Biomedicines, Inc. specializes in developing a generative biology platform aimed at inventing novel therapeutic proteins, including antibodies, peptides, enzymes, and other related compounds. Utilizing advanced machine learning techniques, the platform analyzes the genetic code that determines protein function, allowing for the creation of new protein sequences optimized for therapeutic applications. This innovative approach enables the company to generate proteins that interact specifically and effectively with targeted therapeutic needs, facilitating the development of new drugs across various protein modalities. Founded in 2018 and located in Cambridge, Massachusetts, Generate Biomedicines was previously known as Generate Biologics, Inc. until its name change in March 2020.
SHINE Medical Technologies, LLC is a manufacturer and supplier of medical tracers and cancer treatment elements, specializing in isotopes used for diagnostic and therapeutic purposes. The company produces molybdenum-99, which is essential for imaging and diagnosing conditions such as cancer and heart disease. Additionally, SHINE offers Iodine-131 for the treatment of thyroid cancer and related conditions, as well as Iodine-125, which is utilized in brachytherapy for various cancers. The company also provides Xenon-133, an inhalable gas that assists in evaluating lung function and blood flow in the brain. Founded in 2010 and headquartered in Janesville, Wisconsin, SHINE serves both domestic and international markets with its innovative medical solutions.
Brio Systems, Inc. operates a comprehensive COVID-19 testing platform designed to assist employers in maintaining workplace safety through on-site testing. Founded in 2017 and based in Boston, Massachusetts, the company provides access to lab-backed polymerase chain reaction (PCR) and antibody testing, along with logistics support, medical oversight, and digital results communication within three days of test collection. Brio’s platform connects employers with FDA-certified laboratories, offering a turnkey solution that includes laboratory testing, fulfillment of collection kits, test requisitioning, medical supervision, and digital reporting. Serving various industries such as manufacturing and food processing, Brio Systems facilitates up to 50,000 tests daily, enabling businesses to protect their workforce and make informed risk-mitigation decisions.
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.
Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.
Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.
We provide high quality and personalized health care for vulnerable populations - on their terms, where they are at. We’ve built technology that allows us to dynamically customize individual care plans and ensure reliable care delivery at scale, through telehealth, community-based, and digital modalities. By tightly integrating and coordinating medical and behavioral care we deliver superior value to patients and managed care organizations.
Glympse Bio, Inc. is focused on developing innovative diagnostic solutions that facilitate noninvasive monitoring of various diseases, including cancer, fibrosis, immunological disorders, and infectious diseases. The company employs modular nanoparticle sensors, utilizing precisely engineered diagnostic agents that assess disease states within the body and convey this information through urine analysis. This approach allows for predictive monitoring and evaluation of treatment responses. Founded in 2015 and based in Cambridge, Massachusetts, Glympse Bio's technology is rooted in research originally conducted at MIT and led by a team of experts in nanomedicine and biomedical engineering. Their flagship product, Glympse Inside, serves as a comprehensive platform for disease monitoring and aims to revolutionize how diseases are diagnosed and managed.
Brio Systems, Inc. operates a comprehensive COVID-19 testing platform designed to assist employers in maintaining workplace safety through on-site testing. Founded in 2017 and based in Boston, Massachusetts, the company provides access to lab-backed polymerase chain reaction (PCR) and antibody testing, along with logistics support, medical oversight, and digital results communication within three days of test collection. Brio’s platform connects employers with FDA-certified laboratories, offering a turnkey solution that includes laboratory testing, fulfillment of collection kits, test requisitioning, medical supervision, and digital reporting. Serving various industries such as manufacturing and food processing, Brio Systems facilitates up to 50,000 tests daily, enabling businesses to protect their workforce and make informed risk-mitigation decisions.
MD Ally, Inc. is a telemedicine platform focused on enhancing emergency medical services (EMS) through innovative triage solutions. Established in 2020 and headquartered in Philadelphia, Pennsylvania, the company aims to bridge non-emergency care gaps by integrating telemedicine into emergency dispatch processes. This allows EMS personnel to effectively triage patients with non-life-threatening conditions, directing them to virtual medical and behavioral healthcare professionals, as well as follow-up care and social services. MD Ally's platform is designed collaboratively by EMS and emergency room practitioners, making it user-friendly for public safety entities. By providing this technology, MD Ally seeks to improve patient outcomes, reduce response times, and optimize the use of emergency resources, ultimately contributing to better overall healthcare delivery.
Mission Bio, Inc. specializes in tools for studying cellular heterogeneity in human health and life science research. The company utilizes microfluidic droplet technology to provide solutions for molecular analysis at the single-cell level. Its flagship product, the Tapestri Platform, is the first single-cell multi-omics platform, allowing for the simultaneous detection of genotype and phenotype from the same cell, which enhances the understanding of disease progression and treatment responses. Additionally, Mission Bio offers Tapestri Designer, a cloud-based tool for creating targeted single-cell DNA custom panels, applicable in various fields including oncology, blood cancers, solid tumors, and genome editing validation. Founded in 2011 and based in South San Francisco, California, the company was previously known as Torrent Bio, Inc. before rebranding in 2013.
Thirty Madison, Inc. is a digital health company based in Astoria, New York, focused on providing specialized care for chronic conditions through its web-based platforms. Founded in 2016, the company operates several condition-specific brands: Keeps, which offers a subscription service for men's hair loss prevention medications; Cove, which provides online consultations and prescriptions for migraine treatment; and Evens, designed to manage acid reflux. By offering these tailored services, Thirty Madison aims to increase access to affordable healthcare solutions, addressing the unique needs of patients suffering from these conditions.
Matchwell LLC operates an online marketplace designed to connect clinicians with healthcare facilities. Founded in 2017 and based in Durham, North Carolina, the platform allows healthcare professionals, including nurses and therapists, to join preferred facility pools and access available shift information. Clinicians can communicate directly with facility hiring managers to discuss opportunities, facilitating a streamlined recruitment process for both parties. By offering options for short-term and long-term contracts, Matchwell aims to meet the diverse employment needs of healthcare professionals while helping facilities fill staffing gaps effectively.
WelbeHealth is a healthcare organization dedicated to enhancing the quality of life for frail seniors through the PACE (Program of All-Inclusive Care for the Elderly) model. Founded by experienced physician entrepreneurs, the company provides comprehensive medical and social care, ensuring that participants receive coordinated support that includes medical and dental care, therapy services, transportation, and meal provisions. By focusing on the diverse needs of the elderly population, WelbeHealth aims to help them live longer, healthier, and more independent lives. The leadership team comprises professionals from prominent payer and provider organizations, reflecting a commitment to innovative and compassionate care. Through its holistic approach, WelbeHealth strives to unlock the potential of vulnerable seniors in the community, fostering an environment of empathy and support.
Medivis is a developer of advanced medical imaging technology that utilizes augmented reality and artificial intelligence to enhance surgical operations. The company's innovative platform enables physicians to overlay holographic images directly onto patients during procedures, facilitating precise decision-making in the operating room. By integrating these technologies, Medivis aims to improve surgical outcomes and streamline the workflow for healthcare professionals, ultimately advancing the field of surgical navigation.
Asto CT LLC specializes in developing X-ray computed tomography (CT) systems specifically for equine imaging, aimed at enhancing the care and safety of thoroughbreds, show, recreational, and older horses. Founded in 2015 and based in Madison, Wisconsin, the company offers advanced imaging solutions that improve fracture risk detection, diagnose lameness, and address dental and sinus issues without the need for general anesthesia. Their flagship product, Equina, provides rapid 3D imaging of horses' lower limbs, head, and neck while ensuring a safe and comfortable environment for the animals. By integrating cutting-edge robotics with advanced multi-slice CT technology, Asto CT enhances veterinary diagnostics and treatment, particularly for conditions affecting the distal limb and diseases of the head and neck.
NeuroFlow, Inc. is a digital health company that offers a cloud-based platform designed to enhance access to behavioral health services and improve patient engagement across various care settings. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides tools for remote patient monitoring and integrates behavioral health into practices such as psychology, primary care, and pain management. The platform is HIPAA-compliant and utilizes evidence-based practices to help healthcare providers track and assess patients' mental health, aiming to increase engagement and compliance. NeuroFlow serves a diverse range of clients, including healthcare practices, hospitals, health systems, health plans, and individuals. The company has established strategic partnerships with organizations such as Mental Health America and the National Science Foundation to further its mission of optimizing mental wellness and improving health outcomes.
Emme, Inc. is a healthcare technology company based in San Francisco, California, focused on improving women's reproductive health through innovative solutions. The company designs and develops an integrated smart case device and mobile application aimed at helping women adhere to their birth control regimens by reducing the incidence of missed pills. The Emme Smart Case employs multi-sensor technology to track pill intake and provides notifications when back-up contraception is needed. Additionally, the accompanying app offers users a comprehensive platform to monitor various aspects of their health, including menstrual cycles, mood, and side effects. By combining these technologies, Emme aims to empower women to take control of their reproductive health in a modern and user-friendly manner.
Notable Labs, Inc. develops and operates a platform that provides lab testing services for brain cancer patients. The company runs drug combination experiments on the tumor and gives a report back to the patient’s doctor. Notable Labs, Inc. was formerly known as StemCycle, Inc. The company was incorporated in 2014 and is based in Foster City, California.
miRecule, Inc. is a biotechnology company specializing in the development of microRNA-based therapeutics, with a focus on addressing challenges in cancer treatment and other diseases such as muscular dystrophy. Founded in 2016 and headquartered in Gaithersburg, Maryland, the company has created a drug discovery platform called DREAmiR. This platform leverages genomic and outcome data from thousands of patients to identify genetic changes linked to diseases. It combines genomic sequencing, expression, and prognostic data from cancer patients with high-throughput screening data to pinpoint microRNA candidates for replacement therapy. miRecule's approach aims to formulate these candidates into tumor-targeted nanoparticles, enabling oncologists to effectively target and eliminate drug-resistant cancer cells.
Tembo Health is a telemedicine company serving retirement homes, senior care centers and skilled nursing facilities to connect patients with specialty services like psychiatry and cardiology. The platform connects the specialists to patient data and collaborates with the nursing staff to provide better care plans.
miRecule, Inc. is a biotechnology company specializing in the development of microRNA-based therapeutics, with a focus on addressing challenges in cancer treatment and other diseases such as muscular dystrophy. Founded in 2016 and headquartered in Gaithersburg, Maryland, the company has created a drug discovery platform called DREAmiR. This platform leverages genomic and outcome data from thousands of patients to identify genetic changes linked to diseases. It combines genomic sequencing, expression, and prognostic data from cancer patients with high-throughput screening data to pinpoint microRNA candidates for replacement therapy. miRecule's approach aims to formulate these candidates into tumor-targeted nanoparticles, enabling oncologists to effectively target and eliminate drug-resistant cancer cells.
Meditrina, Inc., founded in 2016 and based in San Jose, California, specializes in developing innovative medical devices for tissue removal solutions related to intrauterine pathology. The company provides the Aveta system, designed for healthcare professionals to facilitate hysteroscopic diagnostic and therapeutic procedures, including the removal of polyps and fibroids. In addition to its tissue removal products, Meditrina is also focused on creating fully disposable endoscopes and a comprehensive visualization system intended for use in both office and clinical settings, catering to various medical procedures.
Meditrina, Inc., founded in 2016 and based in San Jose, California, specializes in developing innovative medical devices for tissue removal solutions related to intrauterine pathology. The company provides the Aveta system, designed for healthcare professionals to facilitate hysteroscopic diagnostic and therapeutic procedures, including the removal of polyps and fibroids. In addition to its tissue removal products, Meditrina is also focused on creating fully disposable endoscopes and a comprehensive visualization system intended for use in both office and clinical settings, catering to various medical procedures.
Olaris, Inc. is a biotechnology company based in Waltham, Massachusetts, focused on developing a precision medicine diagnostic platform aimed at improving disease diagnosis and treatment. Founded in 2013, Olaris specializes in metabolite profiling and personalized biomarkers of response, utilizing advanced machine learning algorithms. This innovative approach allows healthcare providers to identify the most effective treatments for individual patients, thereby optimizing clinical outcomes and minimizing adverse effects associated with therapies. Through its metabolomics platform, Olaris seeks to transform the way diseases, particularly breast cancer, are diagnosed and managed.
HENRY rolls up to corporate offices with a state-of-the-art mobile dental practice and has a brick-and-mortar facility in New Providence, New Jersey. They deliver in-network dental services at your company site through a high-end, technology enabled mobile practice. We charge your company's insurance, not your employees. It's a win-win.
Kenshō is a health company based in Los Angeles that operates an online platform designed to connect users with verified wellness providers. Founded by entrepreneurs Krista Berlincourt and Danny Steiner, the company emphasizes a holistic approach to health, integrating mind, body, and spirit. Kenshō's platform allows users to easily find and book a variety of wellness services, including acupuncture, massage, yoga, naturopathy, and meditation, facilitating access to curated professionals without the need for in-person visits. By combining scientific research with personalization technology, Kenshō aims to simplify the journey toward holistic health, providing users with trustworthy answers and resources for maintaining a balanced and healthy lifestyle.
Luma Health Inc. is a San Francisco-based company that develops a patient engagement platform aimed at facilitating communication between healthcare providers and patients. Founded in 2015, the platform is designed to help healthcare systems and clinics efficiently manage patient appointments, including smart scheduling and referral management. It also offers features such as appointment reminders, mobile patient intake, care pathways, and EHR integrations, alongside analytics and insights. By connecting patients to care quickly and ensuring adherence to treatment plans, Luma Health enhances the overall patient experience and helps healthcare providers maintain a full schedule while improving treatment procedures.
E25Bio specializes in the development of rapid diagnostic tests for epidemic fever viruses. It is dedicated to preventing severe downstream health outcomes with the use of mobile, fast, real-time reporting to create unprecedented large datasets to guide informed and timely responses for the control of disease spread.
The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
Brave Care, Inc. is a healthcare provider specializing in urgent pediatric services. Founded in 2017 and based in Portland, Oregon, the company operates clinics that address a variety of childhood illnesses and injuries. Services offered include treatment for allergies, asthma, coughs, ear pain, eye problems, fever, and urinary tract infections. Brave Care also provides care for minor fractures, strains, sprains, and head trauma, along with pediatric-specific laboratory services and on-site x-ray capabilities. The clinics are equipped to perform procedures such as stitches and tissue glue application for wound closure, as well as mild sedation for uncomfortable treatments.
Nurx Inc. is a healthcare services company that operates a mobile health platform designed to provide easy access to a variety of everyday medications, including contraceptives, travel medications, and treatments for sexual health issues. The platform offers services such as doctor prescription and review, home HPV screening tests, and at-home STI testing. Users can manage their healthcare needs conveniently, with options for automatic prescription refills and renewals, all without the necessity of in-person consultations. Nurx aims to empower individuals, particularly women, by offering transparent pricing and judgment-free care, allowing them to take control of their health decisions. The company serves residents across multiple states, including California, Florida, New York, and Texas. Founded in 2015 and based in San Francisco, Nurx emphasizes personalized care through specialized providers and innovative technology.
Sesame, Inc., operating as SesameCare, is a company that offers a platform for booking doctor appointments and accessing medical care. Founded in 2018 and based in New York, SesameCare aims to simplify the healthcare experience by connecting patients directly with doctors, providing upfront pricing and clear descriptions of medical services. This approach is particularly beneficial for uninsured individuals or those opting to pay out-of-pocket, as it addresses common issues such as hidden costs and unexpected charges that often complicate healthcare access. By focusing on transparency and affordability, SesameCare endeavors to make quality healthcare more accessible for all patients.
Parachute Health, LLC is a New York-based company founded in 2015 that specializes in developing a technology platform for ordering durable medical equipment. This platform is designed to enhance patient care by facilitating the efficient coordination of medical equipment and supplies. It integrates seamlessly with electronic medical record systems, allowing healthcare providers to prescribe orders electronically. The platform offers features such as real-time order status updates, digitized signatures, and integrated messaging, which streamline operations and reduce the need for manual data entry. Additionally, it notifies clinicians about patients' insurance qualifications for equipment, thereby improving delivery times for discharged patients. Parachute Health caters to healthcare facilities, providers, and suppliers, aiming to minimize errors and enhance the overall ordering process for medical equipment.
Mahmee is a care management platform focused on enhancing maternal and child healthcare. The company aims to bridge critical gaps in maternal health by connecting patients with healthcare providers through a comprehensive system that integrates health records for mothers and infants. This platform identifies clinical risks and facilitates collaboration among maternity and infant care practitioners, ensuring that physicians and specialists can share care plans effectively. Founded on the principle that every woman deserves compassionate and respectful support during new motherhood, Mahmee strives to provide ongoing professional assistance to mothers, enabling them to thrive in their parenting journey while promoting the healthy development of their infants in the first year of life.
AdaptX operates a healthcare data analytics platform that focuses on delivering automated analytics to frontline clinical staff. Founded in 2016 and based in Seattle, the company emerged from Seattle Children's Hospital and serves hospitals and surgery centers. Through its innovative solutions, AdaptX empowers medical leaders and clinicians to access and analyze data effectively, enabling them to enhance clinical and workflow outcomes. This approach not only improves patient care but also helps reduce costs, thereby transforming clinical operations within the healthcare sector.
Scipher Medicine is a biotechnology company based in Waltham, Massachusetts, that focuses on developing a molecular technology platform to predict patient responses to drug therapies, particularly in cardiovascular and autoimmune diseases. The company offers several diagnostic tests, including PrismDx, which identifies patients who may not respond to specific medications, PrismRA for patients with rheumatoid arthritis, and PrismUC for those with ulcerative colitis. These tests enable healthcare providers to prescribe more suitable alternative therapies for patients who are unlikely to benefit from traditional treatments. Scipher Medicine emphasizes the importance of providing scientifically backed data to improve patient outcomes and enhance treatment decisions. The company has also established a strategic partnership with Ambry Genetics Corporation to further advance its capabilities. Founded in 2014, Scipher Medicine was previously known as DZZOM Delaware Corporation before changing its name in 2015.
Kindbody is a health and technology company focused on providing comprehensive fertility services tailored for modern women. Their offerings include intrauterine insemination, in-vitro fertilization, egg and embryo freezing, as well as support for donors. In addition to fertility treatments, Kindbody provides a range of holistic health services, including maternity care, gynecology, and wellness support. By leveraging modern technology, Kindbody aims to improve access to affordable healthcare, ensuring that women can receive quality services that enhance their overall health and wellbeing.
HENRY rolls up to corporate offices with a state-of-the-art mobile dental practice and has a brick-and-mortar facility in New Providence, New Jersey. They deliver in-network dental services at your company site through a high-end, technology enabled mobile practice. We charge your company's insurance, not your employees. It's a win-win.
Seed Health is a microbial sciences company focused on harnessing the applications of bacteria to enhance human and environmental health. Through collaborations with prominent academic institutions, the company accelerates scientific advancements to create live biotherapeutics and innovative consumer products. Its consumer brand, Seed®, specializes in developing next-generation probiotics tailored for various life stages and body ecosystems. The product offerings include supplements that combine probiotics and prebiotics aimed at providing systemic benefits, such as improving digestive health, skin health, heart health, and supporting micronutrient synthesis. The company's Scientific Advisory Board comprises experts in various fields, including microbiology, immunology, and gastroenterology, further strengthening its commitment to scientific rigor and innovation.
Neuspera Medical Inc. specializes in the development and manufacture of ultra-miniaturized implantable devices designed for neuromodulation therapy, often referred to as "electroceuticals." Utilizing licensed mid-field powering technology, these devices leverage the body as a natural waveguide to deliver energy effectively. Founded in 2013 and based in San Jose, California, Neuspera aims to enhance the quality of life for patients dealing with chronic illnesses by providing less invasive and adaptable treatment options. The company's innovative approach allows for deeper implantation of its devices, offering patients new possibilities in managing their health conditions.
Farcast is a clinical diagnostic company dedicated to providing personalized cancer treatment solutions. Its core technology utilizes a human tumor microenvironment to enable oncologists and drug developers to assess individual tumors and determine their treatment response profiles. This innovative approach aims to surpass traditional biomarker-guided strategies, thereby enhancing access to personalized medicine and improving the clinical management of cancer. Headquartered in Boston, Massachusetts, Farcast also operates a laboratory in Bangalore, India, reflecting its commitment to advancing cancer care through cutting-edge technology.
ClearView MD is a predictive analytics firm that is powering the transition to value-based care by providing health systems interventions that lead to higher patient and staff satisfaction, lower costs, and the ability to treat more patients. ClearView MD identifies inefficiencies on client's workflows, and recommends steps to improve your scheduling, staffing, and facility utilization. The company was founded by Rajiv Sivendran and Artur Menzeleev, with headquarters in Boston, Massachusetts.
NeuroFlow, Inc. is a digital health company that offers a cloud-based platform designed to enhance access to behavioral health services and improve patient engagement across various care settings. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides tools for remote patient monitoring and integrates behavioral health into practices such as psychology, primary care, and pain management. The platform is HIPAA-compliant and utilizes evidence-based practices to help healthcare providers track and assess patients' mental health, aiming to increase engagement and compliance. NeuroFlow serves a diverse range of clients, including healthcare practices, hospitals, health systems, health plans, and individuals. The company has established strategic partnerships with organizations such as Mental Health America and the National Science Foundation to further its mission of optimizing mental wellness and improving health outcomes.
HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, established in 2013. It specializes in providing innovative search, analytics, and imaging solutions primarily for cancer care providers. The company's smart imaging technology supports clinical decision-making by offering real-time, evidence-based insights that enhance diagnostic accuracy and foster collaboration among healthcare professionals. HealthMyne's platform includes features such as automatic tumor staging, dose overlays, specialized reporting, and management of incidental findings, all aimed at improving patient care and optimizing the efficiency of clinical workflows. By integrating electronic health record capabilities with advanced imaging solutions, HealthMyne seeks to reduce care delivery costs while ensuring that clinicians have access to relevant patient information for informed treatment decisions.
Farcast is a clinical diagnostic company dedicated to providing personalized cancer treatment solutions. Its core technology utilizes a human tumor microenvironment to enable oncologists and drug developers to assess individual tumors and determine their treatment response profiles. This innovative approach aims to surpass traditional biomarker-guided strategies, thereby enhancing access to personalized medicine and improving the clinical management of cancer. Headquartered in Boston, Massachusetts, Farcast also operates a laboratory in Bangalore, India, reflecting its commitment to advancing cancer care through cutting-edge technology.
WelbeHealth is a healthcare organization dedicated to enhancing the quality of life for frail seniors through the PACE (Program of All-Inclusive Care for the Elderly) model. Founded by experienced physician entrepreneurs, the company provides comprehensive medical and social care, ensuring that participants receive coordinated support that includes medical and dental care, therapy services, transportation, and meal provisions. By focusing on the diverse needs of the elderly population, WelbeHealth aims to help them live longer, healthier, and more independent lives. The leadership team comprises professionals from prominent payer and provider organizations, reflecting a commitment to innovative and compassionate care. Through its holistic approach, WelbeHealth strives to unlock the potential of vulnerable seniors in the community, fostering an environment of empathy and support.
Bainbridge Health, Inc. is a Philadelphia-based company that develops a clinical intelligence and data analytics platform focused on improving medication safety in hospital systems. Founded in 2016, the company provides solutions specifically for medication safety leaders, including an infusion pump management software known as InfusionWare. This platform allows clinicians to manage infusion data centrally, enhancing patient safety by streamlining data handling and reducing the likelihood of medication errors. Bainbridge Health’s vendor-agnostic approach eliminates the need for cumbersome data management practices, enabling hospitals to mitigate risks associated with medication errors while also lowering avoidable costs.
Heal, Inc. operates an on-demand healthcare platform that connects patients with licensed, background-checked pediatricians and family doctors for house calls and telemedicine services. Founded in 2014 and based in Los Angeles, the company offers its services across several states, including California, Georgia, Maryland, New Jersey, New York, Virginia, Washington, and the District of Columbia. Patients can schedule appointments through Heal's mobile application available on both the App Store and Google Play. The service is designed to provide timely and convenient medical care for various needs, including urgent care, primary care, and preventive care, with costs typically around $99 or covered by select insurance co-pays. Heal aims to enhance the patient experience by making quality healthcare more accessible while ensuring that doctors can practice medicine in a fulfilling way.
RubiconMD, Inc. is a New York-based company that provides an online platform designed to facilitate communication between primary care clinicians and specialists through its eConsult service. This platform enables primary care providers to discuss cases with top specialists, thereby improving patient care and reducing costs. In addition to eConsults, RubiconMD offers a range of services, including a continuing medical education (CME) credit program, live and on-demand CME webinars, and RubiconRx, a clinical pharmacy platform that supports medication access for patients. The company also provides integration services for electronic health records, onboarding and implementation support, and clinician engagement. Founded in 2013, RubiconMD serves a diverse clientele that includes employers, community health centers, correctional health clinicians, health plans, health systems, and direct primary care practices.
RealSelf brings transparency to the elective medical & aesthetic treatment market which represents a wide range of services—from a simple skin treatment to cosmetic surgery. At the heart of RealSelf is a community of people sharing personal experiences, unbiased stories, and candid advice. Thousand of medical experts also participate on RealSelf. Doctors and clinicians have posted over two million answers to questions and routinely upload educational videos, special offers, and patient before & after photos. The company is a Seattle based startup, backed by world-class investors and has achieved profitability.
SHINE Medical Technologies, LLC is a manufacturer and supplier of medical tracers and cancer treatment elements, specializing in isotopes used for diagnostic and therapeutic purposes. The company produces molybdenum-99, which is essential for imaging and diagnosing conditions such as cancer and heart disease. Additionally, SHINE offers Iodine-131 for the treatment of thyroid cancer and related conditions, as well as Iodine-125, which is utilized in brachytherapy for various cancers. The company also provides Xenon-133, an inhalable gas that assists in evaluating lung function and blood flow in the brain. Founded in 2010 and headquartered in Janesville, Wisconsin, SHINE serves both domestic and international markets with its innovative medical solutions.
Emme, Inc. is a healthcare technology company based in San Francisco, California, focused on improving women's reproductive health through innovative solutions. The company designs and develops an integrated smart case device and mobile application aimed at helping women adhere to their birth control regimens by reducing the incidence of missed pills. The Emme Smart Case employs multi-sensor technology to track pill intake and provides notifications when back-up contraception is needed. Additionally, the accompanying app offers users a comprehensive platform to monitor various aspects of their health, including menstrual cycles, mood, and side effects. By combining these technologies, Emme aims to empower women to take control of their reproductive health in a modern and user-friendly manner.
Innoblative Designs, Inc. is a medical device company based in Chicago, Illinois, with an additional office in Mansfield, Massachusetts. Founded in 2013, the company specializes in developing advanced electrosurgical devices, particularly focusing on radiofrequency ablation technology. One of its key innovations is the Sira™ device, a saline-assisted intraoperative radiofrequency ablation tool that employs bipolar current to create a controlled zone of ablation. Sira's unique design, featuring a saline microinfusion system, enhances contact with target tissue and is compatible with standard electrosurgical generators already utilized in operating rooms. This technology offers surgeons a new, effective option for intraoperative ablation of soft tissue, promoting ease of use and adoption in surgical practices.
Siris Medical, Inc. provides artificial intelligence treatment decision support system in radiation therapy for cancer patients. Its product includes InsightRT Software Suite, which enables to manage the patients; QuickMatch, and PlanMD that can be used independently or together. The company was founded in 2013 and is based in Redwood City, California.
Neuspera Medical Inc. specializes in the development and manufacture of ultra-miniaturized implantable devices designed for neuromodulation therapy, often referred to as "electroceuticals." Utilizing licensed mid-field powering technology, these devices leverage the body as a natural waveguide to deliver energy effectively. Founded in 2013 and based in San Jose, California, Neuspera aims to enhance the quality of life for patients dealing with chronic illnesses by providing less invasive and adaptable treatment options. The company's innovative approach allows for deeper implantation of its devices, offering patients new possibilities in managing their health conditions.
RubiconMD, Inc. is a New York-based company that provides an online platform designed to facilitate communication between primary care clinicians and specialists through its eConsult service. This platform enables primary care providers to discuss cases with top specialists, thereby improving patient care and reducing costs. In addition to eConsults, RubiconMD offers a range of services, including a continuing medical education (CME) credit program, live and on-demand CME webinars, and RubiconRx, a clinical pharmacy platform that supports medication access for patients. The company also provides integration services for electronic health records, onboarding and implementation support, and clinician engagement. Founded in 2013, RubiconMD serves a diverse clientele that includes employers, community health centers, correctional health clinicians, health plans, health systems, and direct primary care practices.
HENRY rolls up to corporate offices with a state-of-the-art mobile dental practice and has a brick-and-mortar facility in New Providence, New Jersey. They deliver in-network dental services at your company site through a high-end, technology enabled mobile practice. We charge your company's insurance, not your employees. It's a win-win.
NeuroFlow, Inc. is a digital health company that offers a cloud-based platform designed to enhance access to behavioral health services and improve patient engagement across various care settings. Founded in 2016 and headquartered in Philadelphia, Pennsylvania, NeuroFlow provides tools for remote patient monitoring and integrates behavioral health into practices such as psychology, primary care, and pain management. The platform is HIPAA-compliant and utilizes evidence-based practices to help healthcare providers track and assess patients' mental health, aiming to increase engagement and compliance. NeuroFlow serves a diverse range of clients, including healthcare practices, hospitals, health systems, health plans, and individuals. The company has established strategic partnerships with organizations such as Mental Health America and the National Science Foundation to further its mission of optimizing mental wellness and improving health outcomes.
Harbor MedTech, Inc. is a regenerative medicine company focused on developing and commercializing tissue regeneration products. Founded in 2010 and based in Irvine, California, the company offers a range of innovative solutions including Architect, an extracellular collagen matrix designed for managing various types of wounds such as diabetic ulcers, pressure sores, and surgical wounds. Additionally, Harbor MedTech provides NeuvoCell, a wound therapy specifically for chronic wounds, alongside products aimed at hernia and joint repair, orthopedic soft tissue repair, breast reconstruction, and urogynecological repair. Utilizing its BriDGE platform, the company is expanding its product pipeline to address needs in dermatology, general surgery, and plastic surgery. Harbor MedTech also maintains a strategic partnership with Edwards Lifesciences to enhance its offerings in the market.
HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, established in 2013. It specializes in providing innovative search, analytics, and imaging solutions primarily for cancer care providers. The company's smart imaging technology supports clinical decision-making by offering real-time, evidence-based insights that enhance diagnostic accuracy and foster collaboration among healthcare professionals. HealthMyne's platform includes features such as automatic tumor staging, dose overlays, specialized reporting, and management of incidental findings, all aimed at improving patient care and optimizing the efficiency of clinical workflows. By integrating electronic health record capabilities with advanced imaging solutions, HealthMyne seeks to reduce care delivery costs while ensuring that clinicians have access to relevant patient information for informed treatment decisions.
Respiratory Motion, Inc. is a medical device company that specializes in the development and commercialization of respiratory monitoring technologies. Headquartered in Waltham, Massachusetts, the company focuses on its flagship product, ExSpiron, a point-of-care device designed to non-invasively measure and provide quantitative values for key respiratory parameters, including minute ventilation, tidal volume, and respiratory rate. The ExSpiron has received FDA clearance, allowing it to graphically display lung volumes over time, thereby enabling healthcare providers to acquire precise data on patients’ respiratory function. Founded in 2010, Respiratory Motion aims to enhance the standard of care in respiratory monitoring while improving patient safety and outcomes through cost-effective solutions.
Innoblative Designs, Inc. is a medical device company based in Chicago, Illinois, with an additional office in Mansfield, Massachusetts. Founded in 2013, the company specializes in developing advanced electrosurgical devices, particularly focusing on radiofrequency ablation technology. One of its key innovations is the Sira™ device, a saline-assisted intraoperative radiofrequency ablation tool that employs bipolar current to create a controlled zone of ablation. Sira's unique design, featuring a saline microinfusion system, enhances contact with target tissue and is compatible with standard electrosurgical generators already utilized in operating rooms. This technology offers surgeons a new, effective option for intraoperative ablation of soft tissue, promoting ease of use and adoption in surgical practices.